• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

iRhythm wearable heart monitor raises AFib diagnoses by 52%

cafead

Administrator
Staff member
  • cafead   Sep 02, 2024 at 12:32: PM
via Screening people in primary care with a wearable heart monitor developed by iRhythm was able to increase diagnoses of atrial fibrillation (AFib) by 52%, although it did not result in a reduction in hospitalisations for stroke.

article source
 

<